Crossmark

Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents

Crossref DOI link: https://doi.org/10.1007/s00044-024-03206-2

Published Online: 2024-03-27

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Jie

Zhou, Chi

Li, Bo

Liu, Huaqing

Zhang, Hui

Liu, Lei https://orcid.org/0000-0002-9784-9953
Funding

Funding for this research was provided by:

Anhui Provincial Department of Education (2022AH051424, 2022AH051424)
License Information

Text and Data Mining valid from 2024-03-27

Version of Record valid from 2024-03-27
More Information

Article History

Received: 5 January 2024

Accepted: 14 February 2024

First Online: 27 March 2024

Compliance with ethical standards

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below